16
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Synthetic piperidine-substituted Chalcones As Potential Hits for α-amylase Inhibitory and Antioxidant Activities

, , ORCID Icon, ORCID Icon, , , ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Pages 497-515 | Received 31 Dec 2022, Accepted 13 Mar 2023, Published online: 24 Apr 2023

References

  • Saleem F , KhanKM, UllahNet al. Pyridones as dual inhibitors of α-amylase and α-glucosidase enzymes and potential antioxidants synthesis, characterization, in vitro, and in silico studies. Arch. Pharm.356(1), e2200400 (2022).
  • Sidik SM , AhmadR. Dietary management of a patient with diabetes mellitus: a case report. Malays. J. Nutr.9(2), 137–144 (2003).
  • Apostolidis E , KwonYI, ShettyK. Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Innov. Food Sci. Emerg. Technol.8(1), 46–54 (2007).
  • Tiwari AK , RaoJM. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Curr. Sci.83(1), 30–38 (2002).
  • Funke I , MelzigMF. Traditionally used plants in diabetes therapy: phytotherapeutics as inhibitors of alpha-amylase activity. Rev. Bras. Farmacogn.16(1), 1–5 (2006).
  • Sales PM , SouzaPM, SimeoniLA, MagalhãesPO, SilveiraD. α-Amylase inhibitors: a review of raw material and isolated compounds from plant source. J. Pharm. Pharm. Sci.15(1), 141–183 (2012).
  • Inzucchi SE . Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA287(3), 360–372 (2002).
  • Whitcomb DC , LoweME. Human pancreatic digestive enzymes. Dig. Dis. Sci.52(1), 1–17 (2007).
  • Kandra L . α-Amylases of medical and industrial importance. J. Mol. Struc. THEOCHEM666, 487–498 (2003).
  • Gupta R , GigrasP, MohapatraH, GoswamiVK, ChauhanB. Microbial α-amylases: a biotechnological perspective. Process Biochem.38(11), 1599–1616 (2003).
  • Cheng AY , FantusIG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ172(2), 213–226 (2005).
  • Yang H , JinX, LamCWK, YanSK. Oxidative stress and diabetes mellitus. Clin. Chem. Lab. Med.49(11), 1773–1782 (2011).
  • Ni L , MengCQ, SikorskiJA. Recent advances in therapeutic chalcones. Expert Opin. Ther. Pat.14(12), 1669–1691 (2004).
  • Sahu NK , BalbhadraSS, ChoudharyJ, KohliDV. Exploring pharmacological significance of chalcone scaffold: a review. Curr. Med. Chem.19(2), 209–225 (2012).
  • Wong E . The role of chalcones and flavanones in flavonoid biosynthesis. Phytochemistry7(10), 1751–1758 (1968).
  • Aksöz BE , ErtanR. Chemical and structural properties of chalcones I. Fabad J. Pharm. Sci.36, 223–242 (2011).
  • Birari RB , GuptaS, MohanCG, BhutaniKK. Antiobesity and lipid-lowering effects of Glycyrrhiza chalcones: experimental and computational studies. Phytomedicine18(8–9), 795–801 (2011).
  • Israf DA , KhaizurinTA, SyahidaA, LajisNH, KhozirahS. Cardamonin inhibits COX and iNOS expression via inhibition of p65NF-κB nuclear translocation and Iκ-B phosphorylation in RAW 264.7 macrophage cells. Mol. Immunol.44(5), 673–679 (2007).
  • Sato Y , HeJX, NagaiH, TaniT, AkaoT. Isoliquiritigenin, one of the antispasmodic principles of Glycyrrhiza ularensis roots, acts in the lower part of intestine. Biol. Pharm. Bull.30(1), 145–149 (2007).
  • Aoki N , MukoM, OhtaE, OhtaS. C-geranylated chalcones from the stems of Angelica keiskei with superoxide-scavenging activity. J. Nat. Prod.71(7), 1308–1310 (2008).
  • Kim DW , Curtis-LongMJ, YukHJet al. Quantitative analysis of phenolic metabolites from different parts of Angelica keiskei by HPLC–ESI MS/MS and their xanthine oxidase inhibition. Food Chem.153, 20–27 (2014).
  • Yamamoto T , YoshimuraM, YamaguchiFet al. Anti-allergic activity of naringenin chalcone from a tomato skin extract. Biosci. Biotechnol. Biochem.68(8), 1706–1711 (2004).
  • Cho S , KimS, JinZet al. Isoliquiritigenin, a chalcone compound, is a positive allosteric modulator of GABAA receptors and shows hypnotic effects. Biochem. Biophys. Res. Commun.413(4), 637–642 (2011).
  • Chen M , ChristensenSB, BlomJet al. a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania. Antimicrob. Agents Chemother.37(12), 2550–2556 (1993).
  • Mukherjee S , KumarV, PrasadAKet al. Synthetic and biological activity evaluation studies on novel 1,3-diarylpropenones. Bioorg. Med. Chem.9(2), 337–345 (2001).
  • De Leon EJ , AlcarazMJ, DominguezJN, CharrisJ, TerencioMC. 1-(2,3,4-trimethoxyphenyl)-3-(3-(2-chloroquinolinyl))-2-propen-1-one, a chalcone derivative with analgesic, anti-inflammatory and immunomodulatory properties. Inflamm. Res.52(6), 246–257 (2003).
  • Higuchi K , WatanabeT, TanigawaT, TominagaK, FujiwaraY, ArakawaT. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist. J. Gastroenterol. Hepatol.25, S155–S160 (2010).
  • Shigeru M , MakotoM, HironakaA, SusumuO. Inhibition of gastric H+, K+-ATPase by the anti-ulcer agent, sofalcone. Biochem. Pharmacol.42, 1447–1451 (1991).
  • Ni L , MengCQ, SikorskiJA. Recent advances in therapeutic chalcones. Expert Opin. Ther. Pat.14, 1669–1691 (2004).
  • Hasan A , KhanKM, SherMet al. Synthesis and inhibitory potential towards acetylcholinesterase, butyrylcholinesterase, and lipoxygenase of some variably substituted chalcones. J. Enzyme Inhib. Med. Chem.20(1), 41–47 (2005).
  • Sultan A , RazaAR, AbbasM, KhanKM, TahirMN, SaariN. Evaluation of silica-H2SO4 as an efficient heterogeneous catalyst for the synthesis of chalcones. Molecules18(8), 10081–10094 (2013).
  • Bale AT , KhanKM, SalarUet al. Chalcones and bis-chalcones: as potential α-amylase inhibitors; synthesis, in vitro screening, and molecular modelling studies. Bioorg. Chem.79, 179–189 (2018).
  • Singh JP , DulawatM, JaitawatN, ChundawatSS, DevpuraA, DulawatSS. Microwave enhanced Claisen–Schmidt condensation: a green route to chalcones. Indian J. Chem.51B, 1623–1627 (2012).
  • Ranganathan K , KamalakkannanD, SureshRet al. Synthesis, Hammett spectral correlation, and evaluation of antimicrobial activities of some substituted styryl 4′-piperidinophenyl ketones. Indian J. Chem. Sec. B58(10), 1131–1148 (2019).
  • Oliveira JR , ShiguemotoCY, das NevesARet al. Design, synthesis and antitubercular activity of novel isoniazid–cyclic-amine–azachalcones hybrids. J. Braz. Chem. Soc.31, 1284–1295 (2020).
  • Yadav N , DixitSK, BhattacharyaAet al. Antimalarial activity of newly synthesized chalcone derivatives in vitro. Chem. Biol. Drug Des.80(2), 340–347 (2012).
  • Babatunde O , HameedS, SalarUet al. Dihydroquinazolin-4 (1H)-one derivatives as novel and potential leads for diabetic management. Mol. Divers.26(2), 1–20 (2021).
  • Kanwal , KhanKM, ChigurupatiSet al. Indole-3-acetamides: As potential antihyperglycemic and antioxidant agents; synthesis, in vitroα-amylase inhibitory activity, structure–activity relationship, and in silico studies. ACS Omega6(3), 2264–2275 (2021).
  • Taha M , IrshadM, ImranSet al. Thiazole-based carbohydrazide derivatives as α-amylase inhibitor and their molecular docking study. Heteroat. Chem.2019, 1–8 (2019).
  • Bale AT , SalarU, KhanKMet al. Chalcones and Bis-chalcones analogs as DPPH and ABTS radical scavengers. Lett. Drug Des. Discov.18(3), 249–257 (2021).
  • Rafique R , KhanKM, ChigurupatiS, SalarU, TahaM, PerveenS. Discovery of new N-hydrazinecarbothioamide indazole hybrids: as potential radical (ABTS and DPPH) scavengers. Lett. Drug Des. Discov.17(9), 1177–1185 (2020).
  • Yousuf S , KhanKM, SalarUet al. 2′-Aryl and 4′-arylidene substituted pyrazolones: as potential α-amylase inhibitors. Eur. J. Med. Chem.159, 47–58 (2018).
  • Ramírez-Escudero M , Gimeno-PérezM, GonzálezBet al. Structural analysis of β-fructofuranosidase from Xanthophyllomyces dendrorhous reveals unique features and the crucial role of N-glycosylation in oligomerization and activity. J. Biol. Chem.291(13), 6843–6857 (2016).
  • Saleem F , KhanKM, ChigurupatiSet al. Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies. Bioorg. Chem.106, 104489 (2021).
  • CCGI . Molecular Operating Environment (MOE), 2013.08.Chemical Computing Group Inc, Montreal (2016).
  • Maurus R , BegumA, KuoHHet al. Structural and mechanistic studies of chloride-induced activation of human pancreatic α-amylase. Protein Sci.14(3), 743–755 (2005).
  • Halgren TA . Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem.17(5–6), 490–519 (1996).
  • Li R , KenyonGL, CohenFEet al. In vitro antimalarial activity of chalcones and their derivatives. J. Med. Chem.38(26), 5031–5037 (1995).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.